# Codex Execution Plan: medication-component-isolated-20260909

Objective: 实现仅用于隔离扩测的用药分项核实合同与校验，不接入产品病史

## Work Items

| Worker | Assigned item | Report |
|---|---|---|
| `worker_01` | 独立脚本及聚焦测试：药名剂量用法途径时间按原摘录分别绑定，禁止跨读道补值，所有输出保持未正式采信 | `runs/execution/medication-component-isolated-20260909/worker_01.md` |

## Manager

No execution manager is dispatched for this route; Codex reviews the worker outputs directly.

## Codex Acceptance

Limited acceptance for isolated experimentation only. Two same-session ZCode/GLM-5.3-Flash:max passes completed; owner verified source and 33 tests, then independent review and owner v3 date checks brought focused coverage to42 tests. No app module or clinical database writes. Runtime v2 has30/30 structurally bound responses but unresolved name/date issues; clinical acceptance and product integration remain unapproved. Expanded plan and raw runs are under artifacts/phase55-takeover/20260909/medication-component*.
